Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-10-22
Original market date: See footnote 1
2020-10-22
Product name:
METHOTREXATE INJECTION BP
Description:
WITH PRESERVATIVE (MULTIDOSE VIALS)
DIN:
02464365
Product Monograph/Veterinary Labelling:
Date:
2024-11-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ACCORD HEALTHCARE INC
3535 Boulevard St-Charles, Suite 704
Kirkland
Quebec
Canada
H9H 5B9
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular , Intra-Arterial , Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01BA01 METHOTREXATE
Active ingredient group (AIG) number:See footnote5
0107545002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| METHOTREXATE (METHOTREXATE SODIUM) | 25 MG / ML |